Clinical Trials

Accrual Status
Limit to SWOG Trials

1040 Results

Status Trial Number Title Sort descending Activated Closed Accrual Phase Published
Closed S0346 Synovial 7/15/2005 12/1/2006 0%
Closed S1607 T-VEC + Pembro in Adv Melanoma follow prog on PD-1 Inhibitor 10/2/2017 11/1/2020 67%
Closed S9805 Tandem transplant in WM 9/1/1998 5/1/2000 18%
Open S2210 Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency 8/14/2023 14%
Open S1900K Targeted Treatment for Advanced NSCLC that has a MET Exon 14 Skipping Gene Change 12/18/2023 29%
Open S1900J Targeted Treatment for Advanced NSCLC with High MET-Amplification 9/27/2024 3%
Closed S9714 Taxol in Stage IIIB & IV BAC 5/15/1997 3/15/2000 100% Published
Closed SWOG-8614 Temporarily Closed: 4/15/90, Chemotherapy of Gastric Cancer with VM-26 10/15/1988 9/15/1990 66% Published
Closed SWOG-9124 Testicular 6/1/1992 9/1/1996 62% Published
Closed SWOG-9316 Testicular 11/1/1995 10/15/1996 2%
Closed S0207 Testicular 4/1/2002 3/1/2005 50% Published
Closed S1105 Text Messaging Study 3/27/2012 9/15/2013 100%
Closed S0508 Thalidomide + Temozolomide in Metastatic Melanoma 6/1/2005 1/1/2007 100% Published
Closed SWOG-8526 The Clinical Antitumor Activity of Recombinant Beta Interferon in Diffuse Mesothelioma 8/1/1986 7/15/1988 Published
Closed SWOG-8244 The Clinical Antitumor Activity of Vinblastine Sulfate in Diffuse Mesothelioma 2/18/1983 3/20/1986 Published
Closed SWOG-8027 The Natural History of Pathological Stage T1-2 N 0 M0 ER + Breast Cancer 10/13/1980 9/10/1982
Closed SWOG-7984 The Treatment of Chronic Stage CML with Pulse, Intermittent Busulfan Therapy with or without Oral Vitamin A 7/10/1980 4/1/1987 Published
Closed SWOG-8375 The Treatment of Favorable Histology Non-Hodgkin's Lymphoma with High Dose Pulse Chlorambucil and Recumbinant DNA Alpha-2 Interferon TEMPORARILY CLOSED: 7/26/85 2/1/1984 3/20/1986
Closed SWOG-8049 The Treatment of Resected, Poor Prognosis Malignant Melanoma: Stage I: Surgical Excision Versus Surgical Excision + Vitamin A 7/29/1981 3/15/1987 Published
Closed SWOG-8111 The Treatment of Resected, Poor Prognosis Malignant: Stage II: Surgical Excision vs. Surgical Excision + Vitamin A vs. Surgical Exicision + Actinomycin-D and DTIC 2/18/1983 3/16/1984
Scroll Table